AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06493162 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Volume Controlled Ventilation
Description: Patients in VCV group will be ventilated with volume controlled ventilation mode
Study NCT04920773 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard guidelines
Description: Practice guidelines to follow physical distancing, respiratory and hand hygiene, wear mask
Study NCT05184829 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Systemic Lymph Node Dissection
Description: Systemic Lymph Node Dissection
Study NCT06130475 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oral Rehydration Solution (ORS)
Description: Participants will be administered the ORS during one of the study visits
Study NCT06130475 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Water
Description: Participants will be administered water during one of the study visits
Study NCT05534672 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rapamycin
Description: Rapamycin in liquid administered orally
Study NCT05534672 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo in liquid administered orally
Study NCT05634993 — intervention group
Intervention type: OTHER
Intervention: Assessment
Description: Assessment of disability level and trunk control
Study NCT05167006 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: routine physical therapy
Description: Each participant will receive his/her arms training therapy. Only one participant per therapist, with or without caregiver observation. Consisting of many purposeful kinesthetic activities such as Graded pinch exercise, Bimanual placing cone, Arm bicycling, Shoulder curved arch, Double-curved arch, Block-stacking, Skateboard-supported arm sliding exercises on a tabletop, Putty kneading, Pegboard exercise, Picking up a ball and putting it into a basket, Plastic cone stacking. Therapists can offer passive, active-assistive, or active training, as deemed appropriate to the patient's ability
Study NCT05167006 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Perfetti's method
Description: . Only one participant per therapist, with or without caregiver observation. Participant will be blindfolded during the exercises and asked to focus on sensing the position of the limb. The therapist will passively move the shoulder, elbow, wrist, or fing
Study NCT05069870 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SKLB1028
Description: SKLB1028, capsule, oral
Study NCT05069870 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: Itraconazole, capsule, oral
Study NCT05069870 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Description: Gemfibrozil, capsule, oral
Study NCT05069870 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifampicin
Description: Rifampicin, capsule, oral
Study NCT04954651 — intervention group
Intervention type: BIOLOGICAL
Intervention: Approved vaccines against Sars-Cov2
Description: Subjects who voluntarily are vaccinated against Sars-Cov-2 with any of the approved vaccines by EU
Study NCT06374043 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Dapagliflozin 10mg Tab
Description: Oral administration
Study NCT06374043 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Oral administration
Study NCT04923984 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Embolization of the middle meningeal artery
Description: embolization of the middle meningeal artery with an embolic agent.
Study NCT04459507 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention will be administered as a part of this study. Both retrospective and prospective data will be collected. The retrospective data will be collected through participant charts and prospective data will be collected in accordance with clinical practice at the participant's clinic visits.
Study NCT05417516 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Whole Breast Irradiation (WBI)
Description: The dose fractionation and prescription is 26Gy in 5 fractions to the PTV once per day over 5-7 days (due to holiday weekends up to 8 days will be acceptable).
Study NCT05417516 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Partial Breast Irradiation (PBI)
Description: The dose fractionation and prescription is 26Gy in 5 fractions to the PTV prescribed at the isocentre of the treatment fields treated once per day over 5-7 days (due to holiday weekends up to 8 days will be acceptable).
Study NCT05710406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Encorafenib
Description: Given PO
Study NCT06044896 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Supine Positioning
Description: The participant will be guided to the Multicare bed and will be positioned supine with the headboard not tilted. At this point, the participant will already have the EIT electrode belt and head, trunk and lower limb cushions around it, providing stability. After the participant has been correctly positioned, ventilatory monitoring will begin using the EIT. The environment must be fully controlled, that is, with adequate lighting, all collection members in silence, as well as the devices in the place, air-conditioned environment, without exposing the participant to heat or cold. Before starting the collection, the volunteer will be asked to try not to sleep or talk, making it clear that any discomfort can be reported at any time. To keep the volunteer awake, visual and sound stimuli can be performed. Furthermore, if you cough or sigh, the collection will restart. The intervention will last 5 minutes and will be repeated twice, with intervals between body lateralization.
Study NCT06044896 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Body Lateral Positioning
Description: The participant will start from the bench press to the 30-degree lateral position. The cushions placed at the beginning of the collection will provide stability so that the inclination does not compromise the correct positioning of the participant, preventing them from sliding on the bed. Furthermore, it is also a safety measure for the participant. The environment will be controlled throughout the intervention and visual and sound effects will also be performed in lateral positioning. The volunteer will remain in this position for five minutes and shortly after will be placed in the supine position again. To start the protocol for the second and final time, the participant will have a washout time of thirty minutes.
Study NCT04909905 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Standard enteral nutrition
Description: Standard enteral nutrition according to ICU nutrition protocol for 7 days
Study NCT04909905 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Glutamine
Description: Intravenous glutamine supplementation to enteral nutrition in a dose of dose of glutamine of 0.4 g/kg/day for 7days
Study NCT05710406 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Given IV
Study NCT06374043 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Withings BPM Connect
Description: CE marked and clinically validated blood pressure monitor. Clinical trial results are within the margin of acceptance defined by the internationally recognized evaluation standard of blood pressure monitors ANSI/AAMI/ISO 81060-2:2013, EN ISO 81060-2:2014, developed by the European Society of Hypertension, British Hypertension Society and Association for the Advancement of Medical Instrumentation/American Heart Association.~Blood pressure will be measured by the participants once daily on 28 days. Three consecutive measurements are taken.
Study NCT05710406 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples
Study NCT05710406 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples
Study NCT05710406 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT05710406 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT
Study NCT05710406 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05710406 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05710406 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient Observation
Description: Undergo observation per usual care
Study NCT05621759 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Nitrogen mustard alkylating agent produced by Bristol-Myers Squibb.
Study NCT05621759 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abatacept
Description: Calcineurin-inhibitor produced by Astellas.
Study NCT05621759 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Description: Selective T cell co-stimulation modulator produced by Bristol-Myers Squibb.
Study NCT04605809 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: combined motor and cognitive training
Description: The combined motor and cognitive training group will receive physical fitness training under sitting and standing, walking training while sequentially or simultaneously perform cognitive training for 45 minutes per session, 3 times a week for 4 weeks.
Study NCT04605809 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: motor training alone
Description: The motor training alone group will receive the same set of physical fitness training while sitting, standing, and walking as the combined motor and cognitive training group for 45 minutes per session, 3 times a week for 4 weeks.
Study NCT04605809 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: cognitive training alone
Description: The cognitive training alone group will receive the same set of cognitive training while sitting as the combined motor and cognitive training group for 45 minutes per session, 3 times a week for 4 weeks.
Study NCT05088252 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Desflurane
Description: After induction, anesthesia will be maintained with 0.7-1.0 MAC desflurane and 0.05-0.3 μg/kg/min remifentanil.
Study NCT05088252 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: After induction, anesthesia will be maintained with 4-6mg/kg/h propofol and 0.05- 0.3 μg/kg/min remifentanil.
Study NCT06374043 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Withings Body+
Description: CE marked and clinically validated advanced Wi-Fi smart scale.~Body weight will be measured by the participants once daily on 40 days.
Study NCT06374043 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Hem-Col Capillary Blood Collection Device
Description: Capillary blood samples will be obtained using a BD Microtainer® Contact-Activated Lancet (Franklin Lakes, New Jersey, USA) once daily on 22 days. These blood samples will be collected into Hem-Col® tubes (Hem-Col, Labonovum, Limmen, the Netherlands), specifically designed for collection of capillary blood acquired through a finger prick. The Hem-Col microtube is equipped with an anticoagulant and a preservation buffer, enhancing the stability of analytes in whole blood. These Hem-Col tubes have the dimensions of standard blood collection tubes and are constructed from polyethylene, featuring a pierceable cap made of thermoplastic elastomers. Each tube incorporates a liquid barrier, with the inner part preventing the loss of Hem-Col preservation fluid and the outer part serving as a scoop for collecting blood from a finger prick. The Hem-Col lithium heparin tubes will be utilized for the analysis of creatinine, CRP, lipid profile, HbA1c, uric acid, glucose and NT-proBNP.
Study NCT06374043 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: MEMS (Medication Electronic Monitoring System) Cap
Description: Medication will be provided in standard medicine bottles with the MEMS® (Medication Electronic Monitoring System) Cap (AARDEX Ltd, Union City, CA, USA), which is a customizable medication package which records and stores up to 4,000 dosing events. The cap fits on standard medicine bottles and with integrated microcircuits, the child-resistant MEMS® Cap records the date and time whenever a patient opens a vial. The stored information can be transferred at any time through the MEMS® Reader to the adherence software for immediate analysis and interpretation.
Study NCT06374043 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Questionnaire: participants' perspectives toward remote data collection
Description: Self-made questionnaires consisting of 6 multiple choice questions and 2 open questions will be used to assess patient experience and satisfaction to guide and inform future trials and use in clinical practice.
Study NCT05728099 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Expiratory muscle strength training + SpiroGym application
Description: Participants will performe an intensive home-based expiratory muscle training programme using an Expiratory Muscle Trainer (EMST150; Aspire Products, LLC, United States), which provide a pressure- threshold range from 30 to 150 cmH20. EMST therapy sessions will be completed at home on 5 days of the patients choosing per week. Participants will be instructed to perform five sets of five forceful expirations coupled with SpiroGym app. per training session for 8 weeks (intensive training period). For another 16 weeks (maintenance period) participants will be instructed to perform, at least twice per week, five sets of five forceful expirations coupled with SpiroGym app. per training session .
Study NCT05728099 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Expiratory muscle strength training
Description: Participants will performe an intensive home-based expiratory muscle training programme using an Expiratory Muscle Trainer (EMST150; Aspire Products, LLC, United States), which provide a pressure- threshold range from 30 to 150 cmH20. EMST therapy sessions will be completed at home on 5 days of the patients choosing per week. Participants will be instructed to perform five sets of five forceful expirations per training session for 8 weeks (intensive training period). For another 16 weeks (maintenance period) participants will be instructed to perform, at least twice per week, five sets of five forceful expirations per training session. Participants will be given the practice log to track training adherence.
Study NCT05519592 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine injection
Description: Intramuscular ropivacaine injection (gluteus maximus and rectus femoris)
Study NCT05519592 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sodium Chloride Injection
Description: Intramuscular sodium chloride injection (gluteus maximus and rectus femoris)
Study NCT05761795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IVMED 85
Description: Eye drop
Study NCT05761795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo eye drop
Study NCT05761795 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo eye drop
Study NCT00012948 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Telephone Care
Study NCT05986942 — intervention group
Intervention type: DRUG
Intervention: Fentanyl
Description: In Group dex, dexmedetomidine infusion will be administered to the patient during the operation. Fentanyl bolus dose will be administered during anesthesia induction in group Fen.
Study NCT05986942 — intervention group
Intervention type: DRUG
Intervention: Dexmedetomidine
Description: In Group dex, dexmedetomidine infusion will be administered to the patient during the operation. Fentanyl bolus dose will be administered during anesthesia induction in group Fen.
Study NCT04086732 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High-frequency electrical stimulation
Description: High-frequency stimulation will be applied on the volar forearm (6-10 cm distal to the cubital fossa). To avoid any confounding effect of handedness, the arm onto which HFS will be applied twice (dominant vs nondominant) will be counterbalanced across participants. HFS will consist of 12 trains of 42 Hz electrical pulses lasting 1 s each. The time interval between each train will be 10 s. The intensity of stimulation will be milliampere. Electrical pulses will be delivered to the skin using a specifically-designed electrode designed: the cathode consists of 16 blunt stainless-steel pins with a diameter of 0.2 mm protruding 1 mm from the base. The 16 pins are placed in a circle with a diameter of 10 mm. The anode consists of a surrounding stainless-steel ring having an inner diameter of 22 mm and an outer diameter of 40 mm. This procedure induces secondary pinprick hyperalgesia (an increase in pinprick sensitivity in a large area of the skin).
Study NCT04799561 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multimodal Teleprehabilitation
Description: Exercise Prescription: patients will be instructed on how to perform aerobic exercise (5 times/week: minimum 30-minute/day) and resistance training (3 times/week: 2-3 sets of 6-8 exercises repeated 8-12 times) at home. Exercise counseling will be weekly, using the video-conferencing application (Zoom).~Nutrition: nutritional status and dietary intake will initially be assessed by the nutritionist using zoom. All patients will receive daily whey protein supplements. Special precautions will be considered if patients have specific medical conditions.~Psychosocial intervention: Patients will have access to 1.5 hours of mental relaxation and coping mechanisms session within the first week of enrolment, using Zoom.~Smoking Cessation: Patients with smoking habits will meet with a respiratory specialist using Zoom, who will establish recommendations and contact the physician for the recommended smoking cessation protocol.~More counseling sessions will be provided as needed.
Study NCT06353776 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conjunctival biopsy after micropulse transscleral laser therapy
Description: During MicroPulse TLT, all patients received periocular anesthesia, with an injection of 5 to 10 ml of Lidocaine (Xylocaine 5mg/ml ®) to achieve complete anesthesia.~The investigators employed the 810 nm Cyclo G6® Laser in its MicroPulse® mode (Iridex Corporation, Mountain View, CA, USA) and delivered laser energy to the eye using the second-generation MicroPulse P3® probe (Iridex Corporation, Mountain View, CA, USA). The laser was calibrated to generate a power output of 2500 mW, and a MicroPulse duty cycle of 31.3%. The curved end of the probe's footplate (bunny ears) was positioned 0.5 to 1 mm away from the corneoscleral limbus, maintaining a perpendicular orientation to the eyeball.~Following the laser therapy, an immediate conjunctival biopsy measuring 2 \* 2 mm and avoiding the laser-treated region was performed.
Study NCT05337397 — intervention group
Intervention type: PROCEDURE
Intervention: Laser ablation
Description: Laser ablation of non-Muscle invasive bladder tumors in outpatient settings.
Study NCT05373056 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scapular program
Description: the patient will be in prone. With the elbow extended, begin by raising the shoulder above the head, keeping the upper extremity in line with the fibers of the lower trapezius. The participant will then remain pronated with the elbow flexed at 90 degrees and the shoulder abducted and externally rotated. Starting from this position, you should exert the force towards external rotation and then return to internal rotation. For the last exercise, the subject will be placed in a standing position holding the elastic band with one hand while the other end will fix it to the ground, while stepping on it with the foot. You will start the movement with a shoulder elevation in the plane of the scapula above 120 degrees and then perform the eccentric returning to the starting position.
Study NCT05373056 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional program
Description: They will be performing a combination of concentric-eccentric type contractions adding an isometric contraction
Study NCT05163015 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: Description: quality of life assessment
Study NCT06431971 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Talineuren
Description: Talineuren infusion weekly
Study NCT06431971 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo infusion weekly
Study NCT05382767 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKDB-501A
Description: Muscle Spasticity
Study NCT05382767 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Botox®
Description: Muscle Spasticity
Study NCT05157802 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity coaching
Description: Physical activity coaching over 5 sessions
Study NCT06055738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zimberelimab
Description: 240mg,d1,iv,Q21D
Study NCT06055738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin-bound Paclitaxel
Description: 260mg/m2,d1,iv,Q21D
Study NCT06055738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: 75mg/m2,d1,iv,Q21D
Study NCT05414357 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Functional Magnetic Resonance Imaging at rest and in activation with attentional task
Description: Participants complete 3 successive assessments (T1: baseline, T2: at 6 months, T3: after galvanic vestibular stimulation). Assessments include:~* Functional and Anatomic Magnetic Resonance Imaging at rest and in activation (only at T1 and T2).~* Biological and physiological measurements~* Spatial memory task~* Cognitive battery~* Questionnaires (sleep, quality of life)